Does PEMBROLIZUMAB Cause Pulmonary toxicity? 318 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 318 reports of Pulmonary toxicity have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.4% of all adverse event reports for PEMBROLIZUMAB.
318
Reports of Pulmonary toxicity with PEMBROLIZUMAB
0.4%
of all PEMBROLIZUMAB reports
35
Deaths
137
Hospitalizations
How Dangerous Is Pulmonary toxicity From PEMBROLIZUMAB?
Of the 318 reports, 35 (11.0%) resulted in death, 137 (43.1%) required hospitalization, and 11 (3.5%) were considered life-threatening.
Is Pulmonary toxicity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 318 reports have been filed with the FAERS database.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Pulmonary toxicity?
AMIODARONE (886)
METHOTREXATE (811)
HYDROXYCHLOROQUINE (411)
RITUXIMAB (404)
TOCILIZUMAB (395)
LEFLUNOMIDE (364)
ABATACEPT (359)
ADALIMUMAB (326)
ETANERCEPT (291)
BLEOMYCIN (263)
Which PEMBROLIZUMAB Alternatives Have Lower Pulmonary toxicity Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G